GLP-1 Appetite Pilot Study
Join a research study exploring appetite and metabolism after stopping tirzepatide, with lifestyle support to help maintain weight loss.
Principle Investigator: Mark Ezpeleta, PhD
COMIRB: #24-1896
Are you starting or currently taking tirzepatide (Zepbound) for weight management?
Curious how it affects your appetite when you stop? This study explores appetite andmetabolism after stopping tirzepatide, with lifestyle support to help maintain weight loss. Help us advance research on how these medications affect appetite and metabolism!
Who can participate?
- 25-60 years old
- Non-smoker
- Do not have type-1 or type-2 diabetes
- Must already be prescribed tirzepatide*
*This study does not provide tirzepatide to participants.
What to expect:
Your involvement may last 3 weeks, with weekly follow-up surveys for up to 15 weeks. Participants will complete two breakfast meal challenges where you will:
- Eat a provided meal while answering surveys
- Give blood samples over a 2-hour period
- Be video recorded for research purposes
Participants may receive up to $200 for completing the study. This study does not provide tirzepatide. Participants must already be prescribed tirzepatide. This study is independently conducted and is not sponsored or affiliated with any pharmaceutical company.